Medicine and Dentistry
Disease
94%
Transplantation
52%
Infection
49%
Rheumatoid Arthritis
47%
Malignant Neoplasm
43%
Non-Hodgkin Lymphoma
43%
Neoplasm
43%
Overall Survival
36%
Chronic Obstructive Pulmonary Disease
35%
COVID-19
31%
Clinical Trial
29%
Human Immunodeficiency Virus
29%
Diffuse Large B-Cell Lymphoma
28%
Diagnosis
23%
Oncology
22%
Hodgkin's Lymphoma
20%
Systematic Review
20%
Breast Cancer
19%
Meta-Analysis
18%
Diabetes
18%
Metastatic Carcinoma
18%
Hematopoietic Stem Cell
18%
Peripheral T-Cell Lymphoma
17%
Drug Megadose
17%
Drug Therapy
16%
T Cell
16%
Biological Marker
16%
Mantle Cell Lymphoma
15%
Acute Myeloid Leukemia
15%
Pediatrics
15%
Cancer
15%
Heart Failure
15%
Symptom
15%
Liver Transplantation
14%
Cell Transplantation
14%
Rheumatology
14%
Clinician
14%
B Cell
14%
Multiple Myeloma
14%
Radiation Therapy
13%
Prevalence
13%
Hazard Ratio
13%
Health Care Cost
13%
Adverse Event
12%
Surgery
12%
Odds Ratio
12%
Progression Free Survival
12%
Follicular Lymphoma
12%
Rituximab
12%
Injury
12%
Primary Health Care
12%
Coronary Artery Disease
12%
Lung Cancer
12%
Virus Infection
11%
Kidney Graft
11%
Biopsy
11%
Hematopoietic Stem Cell Transplantation
11%
Quality of Life
10%
Bone Marrow Transplantation
10%
Stem Cell
10%
Antibiotics
10%
Randomized Controlled Trial
10%
Cardiovascular System
10%
Severe Acute Respiratory Syndrome Coronavirus 2
10%
B-Cell Chronic Lymphocytic Leukemia
10%
Cohort Analysis
10%
Myocardial Infarction
10%
Echocardiography
10%
Epithelial Cell
10%
Tumor Cell
10%
Placebo
10%
Kidney Transplantation
9%
Combination Therapy
9%
Disease Activity
9%
Dobutamine
9%
Autologous Stem Cell Transplantation
9%
Non Small Cell Lung Cancer
9%
Percutaneous Coronary Intervention
9%
Pancreas Cancer
9%
Health Care
9%
Large-Cell Lymphoma
9%
Cardiac Magnetic Resonance Imaging
9%
Cardiovascular Disease
9%
Immunotherapy
9%
In Vitro
9%
B-Cell Lymphoma
8%
Cancer Cell
8%
Methotrexate
8%
Immunosuppressive Treatment
8%
Pathogen
8%
Hematologic Malignancy
8%
Targeted Therapy
8%
Rheumatic Disease
8%
Tumor Progression
8%
Smoking
8%
Multivariate Analysis
8%
Autotransplantation
8%
Liver Disease
8%
Antiretroviral Therapy
8%
High Dose Chemotherapy
7%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Rheumatoid Arthritis
60%
Malignant Neoplasm
54%
HIV
53%
Mouse
48%
Infection
47%
Chronic Obstructive Lung Disease
41%
Ethanol
39%
Neoplasm
37%
Clinical Trial
35%
Chemotherapy
31%
Heart Failure
26%
Nonhodgkin Lymphoma
24%
Pharmacokinetics
23%
Adverse Event
23%
Placebo
21%
Overall Survival
21%
Inflammation
20%
Biological Marker
19%
Receptor
17%
Nanoparticle
16%
Combination Therapy
16%
Methotrexate
15%
Cytokine
15%
Coronavirinae
14%
Breast Cancer
14%
Symptom
13%
Injury
13%
Pancreas Cancer
13%
Liver Disease
13%
Cardiovascular Disease
13%
Cigarette Smoke
13%
Randomized Controlled Trial
12%
Liver Injury
12%
Remission
12%
Heart Infarction
12%
Small Interfering RNA
12%
Cohort Study
11%
Coronary Artery Disease
11%
Lung Cancer
11%
Disease Activity
11%
SARS Coronavirus
11%
Diffuse Large B Cell Lymphoma
10%
Progression Free Survival
10%
Comorbidity
10%
Antibiotics
10%
Tumor Necrosis Factor
10%
Malonaldehyde
10%
Prostate Cancer
10%
Multiple Myeloma
10%
Fluorocarbon
9%
Doxorubicin
9%
Alcohol Liver Disease
9%
Vitamin D
9%
Prevalence
9%
Disease Modifying Antirheumatic Drug
9%
Antiinfective Agent
9%
Collagen Gel
9%
Rituximab
9%
Hodgkin Disease
9%
Infectious Agent
9%
Acute Myeloid Leukemia
8%
Mouse Model
8%
Epileptic Absence
8%
Efavirenz
8%
Human Immunodeficiency Virus Infection
8%
Lenalidomide
8%
Prodrug
8%
Mantle Cell Lymphoma
8%
Tumor Growth
7%
Metastasis
7%
Fibrosis
7%
Dobutamine
7%
Antibiotic Agent
7%
Non Insulin Dependent Diabetes Mellitus
7%
Cyclophosphamide
7%
Glucose
7%
Human Immunodeficiency Virus 1
7%
Hematologic Malignancy
7%
Cytotoxicity
7%
Trimethylglycine
7%
Antioxidant
7%
Sepsis
6%
Pancreas Adenocarcinoma
6%
Tumor Necrosis Factor Inhibitor
6%
Diabetes Mellitus
6%
Prednisone
6%
All Cause Mortality
6%
Angiotensin II
6%
Biological Product
6%
Fibronectin
6%
High Dose Chemotherapy
6%
Biodistribution
6%
Disease Exacerbation
6%
Pharmacotherapy
6%
Rilpivirine
6%
Pig
6%
Peripheral T Cell Lymphoma
6%
Virus Infection
6%
Side Effect
6%
Keyphrases
Rheumatoid Arthritis
25%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
19%
Non-Hodgkin Lymphoma
19%
Lymphoma
16%
Ethanol
14%
Chronic Obstructive Pulmonary Disease
14%
Confidence Interval
13%
Diffuse Large B-cell Lymphoma (DLBCL)
12%
Human Immunodeficiency Virus Type 1 (HIV-1)
12%
Chemotherapy
12%
Overall Survival
12%
COVID-19
11%
Liver
11%
NCCN Guidelines
11%
Clinical Trials
10%
Peripheral T-cell Lymphoma
9%
Oncology
9%
United States
9%
Transplantation
8%
Clinical Practice Guidelines
8%
Heart Failure
8%
Alcohol
8%
Hepatocytes
8%
Acute Myeloid Leukemia
8%
T Cells
7%
Tumor
7%
Multiple Myeloma
7%
Alcoholic Liver Disease
7%
Relapsed or Refractory
7%
Inflammation
7%
American College of Rheumatology
6%
Bone Marrow Transplantation
6%
Lung
6%
Mantle Cell Lymphoma
6%
Hodgkin Disease
6%
Acetaldehyde
6%
Chronic Heart Failure
6%
AIDS/HIV
6%
Allogeneic Bone Marrow Transplantation
6%
Bone Marrow
5%
Follicular Lymphoma
5%
High-dose Chemotherapy
5%
Marrow Transplantation
5%
Clinical Outcomes
5%
Antiretroviral Therapy
5%
In Cancer
5%
Meta-analysis
5%
High-dose Therapy
5%
Initial Treatment
5%
Older Patients
5%
Fibroblasts
5%
Methotrexate
5%
High Risk
5%
Cigarette Smoking
5%
Disease-modifying Antirheumatic Drugs (DMARDs)
5%